Common Low-Cost Antioxidant Enzyme Is Potential Treatment for COVID-19
Researchers from UCLA and China have found that catalase, a naturally occurring enzyme, holds potential as a low-cost therapeutic drug to treat COVID-19 symptoms and...
The post Common Low-Cost Antioxidant Enzyme Is Potential Treatment for COVID-19 appeared first on SciTechDaily.
Read more »